StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
668
This month
10
This week
3
This year
72
Today
1
Yesterday
1
Publishing Date
2024 - 03 - 11
5
2024 - 01 - 24
3
2024 - 01 - 12
4
2024 - 01 - 08
3
2023 - 12 - 12
3
2023 - 12 - 01
3
2023 - 10 - 23
5
2023 - 09 - 11
4
2023 - 08 - 25
3
2023 - 06 - 28
3
2023 - 06 - 05
3
2023 - 04 - 13
4
2023 - 02 - 13
4
2023 - 02 - 02
3
2022 - 12 - 07
3
2022 - 12 - 06
5
2022 - 11 - 28
4
2022 - 09 - 26
3
2022 - 09 - 19
4
2022 - 08 - 02
3
2022 - 07 - 25
3
2022 - 06 - 27
3
2022 - 06 - 17
3
2022 - 06 - 03
4
2022 - 05 - 25
3
2022 - 05 - 17
3
2022 - 05 - 16
5
2022 - 05 - 05
3
2022 - 04 - 26
3
2022 - 03 - 22
3
2022 - 03 - 21
3
2022 - 03 - 03
3
2022 - 03 - 01
3
2022 - 02 - 22
3
2022 - 02 - 18
3
2022 - 02 - 10
3
2022 - 02 - 07
3
2021 - 11 - 24
3
2021 - 10 - 04
3
2021 - 09 - 17
3
2021 - 08 - 12
4
2021 - 08 - 05
6
2021 - 07 - 28
2
2021 - 07 - 08
2
2021 - 06 - 25
2
2021 - 06 - 18
2
2021 - 06 - 16
2
2021 - 06 - 11
2
2021 - 06 - 10
3
2021 - 06 - 09
2
2021 - 05 - 12
2
2021 - 05 - 11
2
2021 - 05 - 10
2
2021 - 04 - 30
2
2021 - 04 - 21
2
2021 - 04 - 20
2
2021 - 03 - 18
2
2021 - 03 - 16
2
2021 - 03 - 12
2
2021 - 03 - 04
3
Sector
Commercial services
7
Communications
4
Consumer non-durables
8
Consumer services
2
Distribution services
2
Electronic technology
7
Finance
5
Health services
10
Health technology
668
Industrial services
1
Information
2
Manufacturing
67
Mining, quarrying, and oil and gas extraction
2
N/a
32
Non-energy minerals
1
Process industries
11
Producer manufacturing
14
Professional, scientific, and technical services
12
Retail trade
2
Technology services
7
Tags
Agreement
12
Alliances
24
America
28
Antibody
19
Astrazeneca
16
Biotech
28
Breast
11
Breast cancer
13
Cancer
144
Cell
14
Clinical-trials-phase-iii
16
Collaboration
14
Covid-19
8
Diabetes
16
Diagnostic
10
Diagnostics
11
Disease
34
Drug
70
Drug delivery
12
Enhertu
24
Europe
11
Expected
13
Fda
9
Financial
10
Financial results
9
Global
108
Granted
8
Growing
24
Growth
120
Health
9
Her2
27
Her2-
18
Immunotherapy
10
Iot
8
Key
9
License
16
Liver
18
Lung
24
Lung cancer
10
Market
267
Metastatic breast cancer
11
N/a
516
Partnership
8
People
10
Pharma
10
Positive
13
Reach
20
Report
95
Research
73
Respiratory
12
Results
30
Review
11
Set
16
System
9
Technology
10
Therapeutics
71
Therapy
32
Treatment
46
Trial
52
Vaccine
29
Entities
3m company
938
Abb ltd
1433
Abbott laboratories
1796
Abbvie inc.
1029
Accenture plc
602
Alphabet inc.
1304
Amgen inc.
744
Apple inc.
1198
Arcelormittal
592
Arrival
4312
Astrazeneca plc
668
Bank of montreal
545
Becton, dickinson and company
796
Bnp paribas
1768
Boston scientific corporation
577
Bristol-myers squibb company
662
Broadcom inc.
597
Cisco systems, inc.
900
Cummins inc.
542
Danaher corporation
786
Dell technologies inc.
579
Dow inc.
556
Eli lilly and company
1711
Ericsson
1616
Extreme networks, inc.
581
First bank
600
Ford motor company
643
Gartner, inc.
595
General electric company
918
Glaxosmithkline plc
888
Honeywell international inc.
1791
Hubspot, inc.
1400
Intel corporation
955
International business machines corporation
655
Johnson & johnson
4601
Kering
1132
Koninklijke philips n.v.
963
Lithium corp
973
Live nation entertainment, inc.
717
Lockheed martin corporation
576
Medtronic plc
1286
Microsoft corporation
1204
Morgan stanley
4291
Nokia corp
982
Nokia corporation
906
Northrop grumman corporation
589
Novartis ag
1245
Novo nordisk a/s
636
Oracle corporation
1161
Orange
7222
Panasonic corp
651
Pfizer, inc.
693
Sanofi
4555
Sap se
1481
Snowflake inc.
796
Stellantis n.v
536
Teva pharmaceutical industries ltd
633
Thermo fisher scientific inc
1630
Verizon communications inc.
1221
X financial
678
Symbols
ABBV
100
ABT
84
ALKS
5
ALPMF
42
ALPMY
42
AMGN
106
ARTL
17
ATR
6
ATXI
7
AVEO
6
AZN
668
AZNCF
451
BAX
27
BDX
7
BHC
12
BIIB
22
BMY
61
BNTX
8
BSX
5
CGEN
7
CKPT
5
CMXHF
14
CSLLY
14
DERM
6
ENDP
9
ENDPQ
6
FBIO
31
GILD
10
GLAXF
158
GLPG
8
GLPGF
8
GNPX
9
GSK
191
HCM
11
ILMN
7
JAZZ
5
JNJ
117
LLY
98
MBIO
6
MDT
14
MMM
13
MRNA
5
MTLHF
5
MTLHY
5
NBIX
5
NVO
30
NVS
199
NVSEF
172
PBYI
6
PFE
45
PHG
11
RBGLY
6
RBGPF
6
SNY
214
SNYNF
177
TAK
29
TEVA
7
TEVJF
85
TMO
19
VTRS
32
Exchanges
Amex
5
Nasdaq
668
Nyse
410
Crawled Date
2024 - 03 - 11
5
2024 - 01 - 30
3
2024 - 01 - 24
3
2024 - 01 - 12
4
2024 - 01 - 08
3
2023 - 12 - 19
3
2023 - 12 - 12
3
2023 - 10 - 23
5
2023 - 09 - 11
4
2023 - 08 - 25
3
2023 - 06 - 28
3
2023 - 06 - 05
3
2023 - 04 - 13
4
2023 - 02 - 14
3
2023 - 02 - 13
3
2023 - 02 - 02
3
2022 - 12 - 07
3
2022 - 12 - 06
5
2022 - 11 - 28
3
2022 - 09 - 26
3
2022 - 09 - 19
4
2022 - 08 - 02
3
2022 - 07 - 25
3
2022 - 06 - 27
3
2022 - 06 - 17
3
2022 - 06 - 03
4
2022 - 05 - 25
3
2022 - 05 - 17
3
2022 - 05 - 16
5
2022 - 05 - 05
3
2022 - 04 - 26
3
2022 - 03 - 22
3
2022 - 03 - 21
3
2022 - 03 - 03
3
2022 - 03 - 02
3
2022 - 02 - 22
3
2022 - 02 - 18
3
2022 - 02 - 10
3
2022 - 02 - 07
3
2021 - 11 - 24
3
2021 - 10 - 04
3
2021 - 09 - 17
3
2021 - 08 - 12
4
2021 - 08 - 05
6
2021 - 07 - 28
3
2021 - 06 - 18
2
2021 - 06 - 16
2
2021 - 06 - 11
2
2021 - 06 - 10
3
2021 - 06 - 09
2
2021 - 05 - 12
2
2021 - 05 - 11
2
2021 - 05 - 10
2
2021 - 04 - 30
2
2021 - 04 - 21
2
2021 - 04 - 20
2
2021 - 03 - 18
2
2021 - 03 - 16
2
2021 - 03 - 12
2
2021 - 03 - 04
3
Crawled Time
00:00
19
00:20
5
01:00
19
01:12
1
02:00
15
03:00
13
03:10
1
04:00
13
04:20
9
05:00
8
06:00
13
07:00
18
08:00
16
09:00
26
09:07
1
10:00
17
11:00
36
12:00
39
12:15
2
12:20
11
12:30
6
13:00
27
13:02
1
13:15
5
13:20
8
13:30
8
13:37
1
14:00
33
14:15
3
14:20
6
14:30
7
15:00
29
15:15
3
15:20
9
15:30
9
16:00
34
16:20
2
17:00
34
18:00
27
19:00
33
19:11
1
20:00
24
21:00
22
21:03
1
22:00
25
23:00
27
23:09
1
Source
investor.aveooncology.com
2
ir.chemocentryx.com
1
www.biospace.com
152
www.chi-med.com
2
www.globenewswire.com
70
www.prnewswire.com
440
www.sutrobio.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Astrazeneca plc
save search
ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Priority Review in the US for patients with HER2-low metastatic breast cancer
Published:
2022-07-25
(Crawled : 12:00)
- biospace.com/
AZN
|
News
|
$70.85
1.03%
1.02%
490K
|
Health Technology
|
8.58%
|
O:
1.43%
H:
0.39%
C:
-0.04%
enhertu
granted
review
cancer
her2-
her2
metastatic breast cancer
ENHERTU® Granted Priority Review in the U.S. for Patients with HER2 Low Metastatic Breast Cancer
Published:
2022-07-25
(Crawled : 11:00)
- biospace.com/
AZN
|
News
|
$70.85
1.03%
1.02%
490K
|
Health Technology
|
8.58%
|
O:
1.43%
H:
0.39%
C:
-0.04%
enhertu
granted
review
cancer
her2-
her2
metastatic breast cancer
Fortress Biotech Appoints David Jin as Chief Financial Officer
Published:
2022-07-22
(Crawled : 13:20)
- biospace.com/
AZNCF
|
News
|
$140.3
1.13%
-4.19%
0
|
Health Technology
|
11.75%
|
O:
2.95%
H:
0.28%
C:
-0.48%
FBIO
|
$1.81
3.43%
2.23%
190K
|
Health Technology
|
77.45%
|
O:
0.98%
H:
0.0%
C:
-7.76%
AZN
|
News
|
$70.85
1.03%
1.02%
490K
|
Health Technology
|
8.4%
|
O:
-0.29%
H:
0.87%
C:
0.12%
biotech
Human Papillomavirus Vaccine (HPV) Market to Reach $10.8 Bn, Globally, by 2031 at 12.4% CAGR: Allied Market Research
Published:
2022-07-21
(Crawled : 13:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-3.77%
-14.18%
0
|
Health Technology
|
-4.54%
|
O:
6.64%
H:
0.0%
C:
-4.08%
SNYNF
|
News
|
$94.25
1.67%
-2.18%
0
|
Health Technology
|
-10.1%
|
O:
-2.38%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$140.3
1.13%
-4.19%
0
|
Health Technology
|
8.0%
|
O:
0.15%
H:
0.0%
C:
-3.5%
NVS
|
News
|
$97.28
2.27%
1.47%
190K
|
Health Technology
|
17.38%
|
O:
0.09%
H:
1.9%
C:
1.89%
JNJ
|
News
|
$149.56
0.3%
0.03%
140K
|
Health Technology
|
-13.08%
|
O:
-1.18%
H:
0.0%
C:
0.0%
GSK
|
News
|
$41.24
1.6%
0.0%
1.6K
|
Health Technology
|
-0.87%
|
O:
1.3%
H:
0.38%
C:
-0.38%
XBIO
|
$3.85
2.39%
7.32%
2.7K
|
Health Technology
|
-95.37%
|
O:
0.41%
H:
7.44%
C:
-2.71%
SNY
|
News
|
$47.69
1.15%
1.13%
1.1K
|
Health Technology
|
-7.53%
|
O:
-3.38%
H:
0.0%
C:
0.0%
INO
|
$10.37
3.49%
3.09%
0
|
Health Technology
|
365.02%
|
O:
0.0%
H:
1.35%
C:
-5.83%
AZN
|
News
|
$70.85
1.03%
1.02%
490K
|
Health Technology
|
7.69%
|
O:
-2.75%
H:
2.31%
C:
2.15%
research
vaccine
market
Insights on the Biologics Global Market to 2027 - by Source, Product, Disease, Manufacturing and Region
Published:
2022-07-19
(Crawled : 20:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-3.77%
-14.18%
0
|
Health Technology
|
17.29%
|
O:
36.07%
H:
0.0%
C:
-9.7%
AZNCF
|
News
|
$140.3
1.13%
-4.19%
0
|
Health Technology
|
4.27%
|
O:
-3.45%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
|
34.34%
|
O:
-4.54%
H:
3.88%
C:
3.88%
NVS
|
News
|
$97.28
2.27%
1.47%
190K
|
Health Technology
|
14.95%
|
O:
-0.81%
H:
0.05%
C:
-1.27%
JNJ
|
News
|
$149.56
0.3%
0.03%
140K
|
Health Technology
|
-15.02%
|
O:
-2.23%
H:
0.0%
C:
0.0%
GSK
|
News
|
$41.24
1.6%
0.0%
1.6K
|
Health Technology
|
-6.08%
|
O:
-0.48%
H:
0.0%
C:
-4.81%
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
13.12%
|
O:
-0.14%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.1K
|
Health Technology
|
-8.1%
|
O:
-0.62%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
490K
|
Health Technology
|
3.95%
|
O:
-1.88%
H:
0.15%
C:
-1.63%
AMGN
|
News
|
$273.54
0.6%
0.65%
8.5K
|
Health Technology
|
10.6%
|
O:
-0.25%
H:
0.71%
C:
-0.03%
global
market
Artelo Biosciences Completes Enrollment of the First Three Cohorts in its CAReS Study Evaluating ART27.13 for the Treatment of Cancer-Related Anorexia and Weight Loss
Published:
2022-07-19
(Crawled : 13:20)
- globenewswire.com
AZNCF
|
News
|
$140.3
1.13%
-4.19%
0
|
Health Technology
|
4.78%
|
O:
-0.67%
H:
1.97%
C:
1.17%
AZN
|
News
|
$70.85
1.03%
1.02%
490K
|
Health Technology
|
6.75%
|
O:
2.23%
H:
0.8%
C:
0.46%
ARTL
|
News
|
$1.31
0.74%
1.87%
26
|
Health Technology
|
-73.45%
|
O:
0.0%
H:
6.99%
C:
1.61%
art27
treatment
art27.13
study
Insights on the Influenza Vaccine Global Market to 2027 - by Vaccine Type, Technology, Age Group, Route of Administration and Region
Published:
2022-07-13
(Crawled : 19:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-3.77%
-14.18%
0
|
Health Technology
|
-23.0%
|
O:
-3.79%
H:
2.41%
C:
0.26%
SNYNF
|
News
|
$94.25
1.67%
-2.18%
0
|
Health Technology
|
-4.95%
|
O:
-1.46%
H:
0.09%
C:
0.09%
AZNCF
|
News
|
$140.3
1.13%
-4.19%
0
|
Health Technology
|
7.94%
|
O:
-2.09%
H:
1.62%
C:
1.62%
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
|
38.63%
|
O:
-1.35%
H:
0.4%
C:
0.27%
NVS
|
News
|
$97.28
2.27%
1.47%
190K
|
Health Technology
|
19.09%
|
O:
-1.04%
H:
0.62%
C:
0.55%
GSK
|
News
|
$41.24
1.6%
0.0%
1.6K
|
Health Technology
|
-19.37%
|
O:
-1.96%
H:
0.35%
C:
0.25%
ABT
|
News
|
$107.59
0.49%
0.33%
3.1M
|
Health Technology
|
1.3%
|
O:
-1.49%
H:
1.23%
C:
1.03%
SNY
|
News
|
$47.69
1.15%
1.13%
1.1K
|
Health Technology
|
-4.97%
|
O:
-1.27%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
490K
|
Health Technology
|
6.86%
|
O:
-2.73%
H:
0.95%
C:
0.91%
vaccine
influenza
market
Eli Lilly and Co and Novo Nordisk AS Among Leading Companies in the Type 2 Diabetes Pipeline Market | GlobalData Plc
Published:
2022-07-13
(Crawled : 09:00)
- globenewswire.com
AZNCF
|
News
|
$140.3
1.13%
-4.19%
0
|
Health Technology
|
6.29%
|
O:
-0.51%
H:
0.0%
C:
-1.03%
AZN
|
News
|
$70.85
1.03%
1.02%
490K
|
Health Technology
|
6.19%
|
O:
-1.77%
H:
1.83%
C:
1.16%
companies
diabetes
market
Neuroimmunology Drugs Market worth $37.32 billion by 2030 - Exclusive Report by InsightAce Analytic
Published:
2022-07-06
(Crawled : 09:00)
- prnewswire.com
AZNCF
|
News
|
$140.3
1.13%
-4.19%
0
|
Health Technology
|
12.53%
|
O:
9.36%
H:
0.0%
C:
-4.54%
NVS
|
News
|
$97.28
2.27%
1.47%
190K
|
Health Technology
|
18.13%
|
O:
-0.11%
H:
0.5%
C:
0.16%
JNJ
|
News
|
$149.56
0.3%
0.03%
140K
|
Health Technology
|
-16.29%
|
O:
-0.48%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.1K
|
Health Technology
|
-5.97%
|
O:
-0.28%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
490K
|
Health Technology
|
9.45%
|
O:
2.15%
H:
0.79%
C:
0.56%
report
market
drug
A $41.8 Billion Global Opportunity for Small Molecule Drug Discovery by 2026 - New Research from StrategyR
Published:
2022-07-04
(Crawled : 11:00)
- prnewswire.com
PFE
|
News
4
|
$26.32
0.23%
0.15%
88K
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
News
|
$41.24
1.6%
0.0%
1.6K
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$70.85
1.03%
1.02%
490K
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$19.54
-3.77%
-14.18%
0
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$149.56
0.3%
0.03%
140K
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$140.3
1.13%
-4.19%
0
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
$67.03
0.12%
0.12%
15K
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
BMY
|
$48.99
-0.31%
0.41%
7.1M
|
Health Technology
|
Email alert
Add to watchlist
drug
research
Global Cough Syrup Market Report (2022 to 2028) - Featuring AstraZeneca, Abbott Laboratories, Acella Pharmaceuticals and Glenmark Pharmaceuticals Among Others
Published:
2022-07-01
(Crawled : 14:00)
- prnewswire.com
RBGPF
|
News
|
$52.06
0.6%
6.46%
0
|
Consumer Non-Durables
|
-28.59%
|
O:
0.2%
H:
4.46%
C:
0.03%
AZNCF
|
News
|
$140.3
1.13%
-4.19%
0
|
Health Technology
|
8.84%
|
O:
-3.88%
H:
6.2%
C:
5.52%
RBGLY
|
News
|
$10.59
2.32%
-2.05%
2K
|
Manufacturing
|
-29.28%
|
O:
-1.05%
H:
1.59%
C:
1.53%
ABT
|
News
|
$107.59
0.49%
0.33%
3.1M
|
Health Technology
|
-0.83%
|
O:
-0.04%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.1K
|
Health Technology
|
-6.2%
|
O:
0.26%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
490K
|
Health Technology
|
7.23%
|
O:
-2.92%
H:
0.0%
C:
0.0%
report
market
Cancer Immunotherapy Market Expands with Rising Adoption of Target Therapy in Cancer Treatment, States TMR Report
Published:
2022-06-27
(Crawled : 16:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-3.77%
-14.18%
0
|
Health Technology
|
-25.91%
|
O:
0.47%
H:
3.73%
C:
3.73%
SNYNF
|
News
|
$94.25
1.67%
-2.18%
0
|
Health Technology
|
-9.81%
|
O:
4.15%
H:
0.0%
C:
0.0%
AZNCF
|
News
|
$140.3
1.13%
-4.19%
0
|
Health Technology
|
8.58%
|
O:
-1.55%
H:
4.43%
C:
0.03%
PFE
|
News
4
|
$26.32
0.23%
0.15%
88K
|
Health Technology
|
-48.13%
|
O:
1.46%
H:
1.45%
C:
0.78%
NVS
|
News
|
$97.28
2.27%
1.47%
190K
|
Health Technology
|
18.35%
|
O:
1.86%
H:
1.05%
C:
0.24%
GSK
|
News
|
$41.24
1.6%
0.0%
1.6K
|
Health Technology
|
-24.49%
|
O:
-0.16%
H:
0.61%
C:
0.18%
LLY
|
News
|
$745.69
1.96%
0.04%
4K
|
Health Technology
|
131.4%
|
O:
1.32%
H:
0.0%
C:
0.0%
BMY
|
$48.99
-0.31%
0.41%
7.1M
|
Health Technology
|
-37.96%
|
O:
0.34%
H:
1.72%
C:
0.95%
SPPI
|
$1.03
-0.97%
0
|
Health Technology
|
17.05%
|
O:
0.0%
H:
2.28%
C:
-2.27%
SNY
|
News
|
$47.69
1.15%
1.13%
1.1K
|
Health Technology
|
-10.24%
|
O:
0.53%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
490K
|
Health Technology
|
6.54%
|
O:
-0.36%
H:
1.22%
C:
0.38%
immunotherapy
report
therapy
cancer
market
treatment
Cancer Gene Therapy Market to Grow at 10.1% through 2032, Amid High Adoption in Breast Cancer Treatment - Future Market Insights, Inc.
Published:
2022-06-27
(Crawled : 15:20)
- prnewswire.com
GLAXF
|
News
|
$19.54
-3.77%
-14.18%
0
|
Health Technology
|
-25.91%
|
O:
0.47%
H:
3.73%
C:
3.73%
AZNCF
|
News
|
$140.3
1.13%
-4.19%
0
|
Health Technology
|
8.58%
|
O:
-1.55%
H:
4.43%
C:
0.03%
NVS
|
News
|
$97.28
2.27%
1.47%
190K
|
Health Technology
|
18.35%
|
O:
1.86%
H:
1.05%
C:
0.24%
GSK
|
News
|
$41.24
1.6%
0.0%
1.6K
|
Health Technology
|
-24.49%
|
O:
-0.16%
H:
0.61%
C:
0.18%
CRNX
G
|
$44.22
1.8%
1.74%
23
|
Health Technology
|
125.5%
|
O:
0.66%
H:
1.22%
C:
-5.83%
AZN
|
News
|
$70.85
1.03%
1.02%
490K
|
Health Technology
|
6.54%
|
O:
-0.36%
H:
1.22%
C:
0.38%
AMGN
|
News
|
$273.54
0.6%
0.65%
8.5K
|
Health Technology
|
11.48%
|
O:
-0.08%
H:
0.45%
C:
-0.13%
ADAP
|
$1.14
12.87%
9.82%
1.1M
|
Health Technology
|
-29.63%
|
O:
1.85%
H:
6.67%
C:
3.03%
treatment
therapy
cancer
market
Valued to be $12.9 Billion by 2026, Crohn`s Disease (CD) Therapy Slated for Robust Growth Worldwide
Published:
2022-06-27
(Crawled : 12:20)
- prnewswire.com
AZNCF
|
News
|
$140.3
1.13%
-4.19%
0
|
Health Technology
|
8.58%
|
O:
-1.55%
H:
4.43%
C:
0.03%
PFE
|
News
4
|
$26.32
0.23%
0.15%
88K
|
Health Technology
|
-48.13%
|
O:
1.46%
H:
1.45%
C:
0.78%
NVO
|
News
|
$128.64
2.7%
-1.37%
60K
|
Health Technology
|
15.05%
|
O:
0.72%
H:
0.0%
C:
0.0%
NVS
|
News
|
$97.28
2.27%
1.47%
190K
|
Health Technology
|
18.35%
|
O:
1.86%
H:
1.05%
C:
0.24%
JNJ
|
News
|
$149.56
0.3%
0.03%
140K
|
Health Technology
|
-16.97%
|
O:
0.78%
H:
0.94%
C:
0.26%
CCXI
|
News
|
$51.99
-0.04%
|
Health Technology
|
87.83%
|
O:
-4.88%
H:
1.04%
C:
-1.25%
AZN
|
News
|
$70.85
1.03%
1.02%
490K
|
Health Technology
|
6.54%
|
O:
-0.36%
H:
1.22%
C:
0.38%
disease
therapy
growth
Global Opioids Market to 2027 - Size, Share & Industry Trends Analysis Report
Published:
2022-06-24
(Crawled : 21:00)
- prnewswire.com
ENDP
|
News
|
$0.2926
-9.6%
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$94.25
1.67%
-2.18%
0
|
Health Technology
|
Email alert
Add to watchlist
MNKKQ
|
$0.02
|
Manufacturing
|
Email alert
Add to watchlist
AZN
|
News
|
$70.85
1.03%
1.02%
490K
|
Health Technology
|
Email alert
Add to watchlist
PFE
|
News
4
|
$26.32
0.23%
0.15%
88K
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$140.3
1.13%
-4.19%
0
|
Health Technology
|
Email alert
Add to watchlist
MNK
|
$0.3402
-0.06%
540K
|
n/a
|
Email alert
Add to watchlist
SNY
|
News
|
$47.69
1.15%
1.13%
1.1K
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
trends
report
market
Psoriasis Treatment Market Players Observe Rising Trend of Personalized Medicines, According to TMR Report
Published:
2022-06-24
(Crawled : 12:00)
- prnewswire.com
AZNCF
|
News
|
$140.3
1.13%
-4.19%
0
|
Health Technology
|
10.73%
|
O:
0.64%
H:
4.18%
C:
1.33%
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
|
46.19%
|
O:
6.71%
H:
0.0%
C:
-0.1%
PFE
|
News
4
|
$26.32
0.23%
0.15%
88K
|
Health Technology
|
-46.59%
|
O:
2.96%
H:
0.0%
C:
0.0%
NVS
|
News
|
$97.28
2.27%
1.47%
190K
|
Health Technology
|
21.17%
|
O:
2.38%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$149.56
0.3%
0.03%
140K
|
Health Technology
|
-15.36%
|
O:
1.94%
H:
0.0%
C:
0.0%
LLY
|
News
|
$745.69
1.96%
0.04%
4K
|
Health Technology
|
139.07%
|
O:
3.32%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
490K
|
Health Technology
|
11.24%
|
O:
4.41%
H:
0.0%
C:
0.0%
treatment
report
psoriasis
market
Press release Biocartis Group NV: Biocartis Announces New Agreement with AstraZeneca for the Development and Marketing of a Companion Diagnostic Test for Tagrisso®
Published:
2022-06-22
(Crawled : 06:00)
- globenewswire.com
AZN
|
News
|
$70.85
1.03%
1.02%
490K
|
Health Technology
|
13.45%
|
O:
0.77%
H:
1.94%
C:
0.99%
tagrisso
test
diagnostic
agreement
group
Liver Cancer Drugs Market size to grow by USD 5.29 billion | Market Research Insights highlight the increasing incidence of liver cancer as Key Driver | Technavio
Published:
2022-06-21
(Crawled : 03:00)
- prnewswire.com
AZNCF
|
News
|
$140.3
1.13%
-4.19%
0
|
Health Technology
|
16.7%
|
O:
6.34%
H:
0.0%
C:
-4.65%
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
|
46.1%
|
O:
4.65%
H:
0.0%
C:
-4.51%
QBIO
|
$0.0002
100.0%
1.1K
|
Professional, Scientific, and T...
|
-100.0%
|
O:
46.85%
H:
0.0%
C:
-30.95%
NVS
|
News
|
$97.28
2.27%
1.47%
190K
|
Health Technology
|
21.32%
|
O:
1.41%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
490K
|
Health Technology
|
15.75%
|
O:
2.03%
H:
0.0%
C:
0.0%
research
liver
cancer
market
Insights on the Psoriasis Therapeutics Global Market to 2028 - Cumulative Development of New Biologics and New Pipeline Drugs Presents Opportunities
Published:
2022-06-20
(Crawled : 15:20)
- prnewswire.com
ALPMF
|
News
|
$9.5
-2.56%
43.47%
21K
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$140.3
1.13%
-4.19%
0
|
Health Technology
|
Email alert
Add to watchlist
ALPMY
|
News
|
$9.49
-0.42%
-1.11%
55K
|
Manufacturing
|
Email alert
Add to watchlist
AZN
|
News
|
$70.85
1.03%
1.02%
490K
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
News
|
$41.24
1.6%
0.0%
1.6K
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$745.69
1.96%
0.04%
4K
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$19.54
-3.77%
-14.18%
0
|
Health Technology
|
Email alert
Add to watchlist
therapeutics
psoriasis
market
drug
Biologic Therapy Market Information: By Product and Geography - Global Forecast till 2025
Published:
2022-06-17
(Crawled : 14:00)
- prnewswire.com
GLAXF
|
News
|
$19.54
-3.77%
-14.18%
0
|
Health Technology
|
-24.07%
|
O:
0.01%
H:
0.17%
C:
0.17%
SNYNF
|
News
|
$94.25
1.67%
-2.18%
0
|
Health Technology
|
-3.0%
|
O:
-1.76%
H:
5.75%
C:
5.5%
AZNCF
|
News
|
$140.3
1.13%
-4.19%
0
|
Health Technology
|
18.15%
|
O:
1.89%
H:
0.0%
C:
-0.64%
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
|
42.43%
|
O:
0.74%
H:
0.52%
C:
-3.23%
NVS
|
News
|
$97.28
2.27%
1.47%
190K
|
Health Technology
|
21.4%
|
O:
0.07%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$149.56
0.3%
0.03%
140K
|
Health Technology
|
-11.08%
|
O:
1.35%
H:
0.0%
C:
0.0%
GSK
|
News
|
$41.24
1.6%
0.0%
1.6K
|
Health Technology
|
-0.6%
|
O:
-0.24%
H:
0.0%
C:
0.0%
ABBV
|
News
|
$169.54
0.98%
0.18%
3.2M
|
Health Technology
|
24.26%
|
O:
1.05%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.69
1.15%
1.13%
1.1K
|
Health Technology
|
-3.12%
|
O:
1.39%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.85
1.03%
1.02%
490K
|
Health Technology
|
16.43%
|
O:
0.59%
H:
0.0%
C:
0.0%
therapy
market
← Previous
1
2
…
16
17
18
19
20
21
22
23
24
…
33
34
Next →
Gainers vs Losers
74%
26%
Top 10 Gainers
AGBA
|
$2.97
137.6%
54.87%
66M
|
Finance
RILY
|
$21.72
0.84%
32.09%
1.9M
|
Finance
HKIT
|
$1.33
30.39%
27.14%
39K
|
Technology Services
WIMI
|
$0.7254
5.45%
24.7%
4.1M
|
Technology Services
TPET
|
$0.3601
-4.51%
23.11%
11M
|
n/a
VLCN
|
$0.2946
26.38%
17.69%
390K
|
PEGY
|
$0.0566
23.58%
15.65%
11M
|
Manufacturing
VRT
4
|
$79.17
4.08%
15.6%
1.6M
|
Electronic Technology
FOA
4
|
$0.5144
-8.16%
15.43%
20
|
Finance and Insurance
BOF
|
$1.17
6.36%
14.73%
15K
|
Your saved searches
Save your searches and get alerts when important news are released.